Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study T Cell Receptor-Redirected T Cells Infusions in Subjects With Recurrent HBV-Related Hepatocellular Carcinoma in Post Liver Transplantation

NCT02719782 is registered in ClinicalTrials.gov with Lion TCR Pte. Ltd. as lead sponsor.

NCT NCT02719782
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02719782 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study T Cell Receptor-Redirected T Cells Infusions in Subjects With Recurrent HBV-Related Hepatocellular Carcinoma in Post Liver Transplantation
Lead sponsor
Lion TCR Pte. Ltd.
Phase
Phase 1
Overall status
Unknown status
Start date
July 2, 2015
Completion date
December 31, 2019
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent hepatocellular carcinoma